← Leaderboards
Jaime C Chu
Icahn School Of Medicine At Mount Sinai
$3,138,533
Attributed
$3,948,143
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $875K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,948,143 · 4
By mechanism
R01$2,251,591 · 1
R38$1,142,979 · 2
K08$553,573 · 1
Top collaborators
- Emily Jane Gallagher4 shared
- Benjamin K Chen2 shared
- Monica Kraft2 shared
- Neomi A Shah2 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Yelena Ginzburg$4,350,478
- Vahram Haroutunian$39,970,462
- Ernesto Guccione$11,143,318
- Carol Prives$28,176,184
- Christoph Buettner$9,918,421
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseSupplementationPhenotypeMutationMetabolicMutantGeneticMediatingMannoseLiver DiseasesApoptosisCirrhosisMetabolic PathwayMetabolismFibrosisCellsHepatocyteGlycosylationChildLinkCongenital DisordersLiverCell DeathZebrafish
Grant awards (18)
Mount Sinai StARR Program - NIAID$346,073
R38 · FY2025 · AI
Mount Sinai StARR Program - NHLBI$346,072
R38 · FY2025 · HL
Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosis$366,120
R01 · FY2024 · DK · contact PI
Mount Sinai StARR Program - NHLBI$225,417
R38 · FY2024 · HL
Mount Sinai StARR Program - NIAID$225,417
R38 · FY2024 · AI
Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosis$58,002
R01 · FY2024 · DK · contact PI
Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosis$381,375
R01 · FY2023 · DK · contact PI
Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosis$99,435
R01 · FY2023 · DK · contact PI
Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosis$381,375
R01 · FY2022 · DK · contact PI
Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosis$41,432
R01 · FY2022 · DK · contact PI
Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosis$381,375
R01 · FY2021 · DK · contact PI
Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosis$378,069
R01 · FY2020 · DK · contact PI
Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosis$164,408
R01 · FY2020 · DK · contact PI
A novel role for p53 in congenital disorders of glycosylation$99,036
K08 · FY2016 · DK · contact PI
A novel role for p53 in congenital disorders of glycosylation$150,876
K08 · FY2015 · DK · contact PI
A novel role for p53 in congenital disorders of glycosylation$869
K08 · FY2015 · DK · contact PI
A novel role for p53 in congenital disorders of glycosylation$151,376
K08 · FY2014 · DK · contact PI
A novel role for p53 in congenital disorders of glycosylation$151,416
K08 · FY2013 · DK · contact PI